I would think Novartis would have a fair idea. I would also think they are MSBs greatest asset in bringing products to market. Current management are amateurs.
It might be possible to better identify who should be targeted but all that is a long way off. As I said previously, other treatment protocols and products which are proven are being discovered every day as Covid goes on. I read an article today which said an existing arthritis drug has shown it assists for severe cases. Cheap. Proven.
Not sure what the price point was slated to be for MSB Covid. Cancer was to be $200k plus. Even if you assume $20k - forget it if it’s meant to be rolled out widely to thousands of people.
MSB Price at posting:
$2.24 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)